Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents
Molecules · 2025
DOI: 10.3390/molecules30081726 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Paola Checconi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department for the Promotion of Human Sciences and Quality of Life, San Raffaele University, Via di Val Cannuta 247, 00166 Rome, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Antineoplastic Agents, Gold, Coordination Complexes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN 2022, Italian Ministry of Health-Ricerca Corrente.
Abstract (Originalsprache)
Approaches capable of simultaneously treating cancer and protecting susceptible patients from lethal infections are highly desirable, although they prove challenging. Taking inspiration from the well-known anticancer platinum complexes, successive studies about the complexation of organic compounds with other late transition metals, such as silver, gold, palladium, rhodium, ruthenium, iridium, and osmium, have led to remarkable anticancer activities. Among the numerous chemical moieties studied, N-heterocyclic carbenes (NHCs) have revealed very attractive activities due to their favorable chemical properties. Specifically, gold–NHC complexes emerged as some of the most active complexes acting as antitumor agents. On the other hand, some recent studies have highlighted the involvement of these complexes in antiviral research as well. The well-known gold-based, orally available complex auranofin approved by the Food and Drug Administration (FDA) for the treatment of rheumatoid arthritis has been suggested as a repositioned drug for both cancer and viral infections. In the era of the COVID-19 pandemic, the most interesting goal could be the discovery of gold–NHC complexes as dual antiviral and anticancer agents. In this review, the most recent studies regarding the anticancer and antiviral activities of gold(I)–NHC complexes will be analyzed and discussed, offering an interesting insight into the research in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for the Promotion of Human Sciences and Quality of Life, San Raffaele University, Via di Val Cannuta 247, 00166 Rome, Italy.
- Laboratory of Microbiology, IRCCS San Raffaele Roma, Via di Val Cannuta 247, 00166 Rome, Italy.
- Department of Basic and Applied Sciences, University of Basilicata, Via dell'Ateneo Lucano, 10, 85100 Potenza, Italy.
- Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", Via Orabona, 4, 70126 Bari, Italy.
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
- Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi, 1, Blocco 11, 67010 L'Aquila, Italy.
ORCID-Profile: Paola Checconi, Annaluisa Mariconda, Alessia Catalano, Jessica Ceramella, Stefano Aquaro, Maria Stefania Sinicropi, Pasquale Longo
Förderung
- PRIN 2022
- Italian Ministry of Health-Ricerca Corrente
Zitieren
APA
Checconi, P., Mariconda, A., Catalano, A., Ceramella, J., Pellegrino, M., Aquaro, S., Sinicropi, M. S., & Longo, P. (2025). Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents. Molecules. https://doi.org/10.3390/molecules30081726
Vancouver
Checconi P, Mariconda A, Catalano A, Ceramella J, Pellegrino M, Aquaro S, et al. Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents. Molecules. 2025. doi:10.3390/molecules30081726
BibTeX
@article{Checconi2025,
author = {Checconi, Paola and Mariconda, Annaluisa and Catalano, Alessia and Ceramella, Jessica and Pellegrino, Michele and Aquaro, Stefano and Sinicropi, Maria Stefania and Longo, Pasquale},
title = {Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30081726}
}
EUVIMED